Kazuto Tajiri

机构：University of the Third Age, Toyama University Hospital, University of Toyama · ORCID：0000-0002-2373-8601

发表论文 249 篇 · 总被引 5795 次 · h-index 41

代表论文

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study (2024 · Liver Cancer · 被引 29)
Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice (2024 · Hepatology Research · 被引 17)
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients (2024 · Alimentary Pharmacology & Therapeutics · 被引 17)
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial (2024 · Alimentary Pharmacology & Therapeutics · 被引 17)
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma (2024 · Cancer Reports · 被引 11)
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab (2024 · Targeted Oncology · 被引 10)